868
Participants
Start Date
March 26, 2018
Primary Completion Date
March 30, 2019
Study Completion Date
June 30, 2019
Sofosbuvir/ledipasvir (SOF/LDV)
"SOF/LDV (400mg/90mg) orally once daily with or without food in the morning and will receive treatment for a duration of 12 weeks.~In addition, Ribavirin weight-based (1000 mg for patients \<75 kg and 1200 mg for those ≥75 kg) administered orally in two divided doses with food for Genotype 3 patients."
Clinic of the Institute of Epidemiology and Infectious Diseases, National Academy of Medical Sciences of Ukraine, Kiev
Kyiv City Clinical Hospital #5, Kyiv
All Ukrainian Network of PLHA
UNKNOWN
Public Health Center of MOH Ukraine
UNKNOWN
Alliance for the Public's Health
OTHER
Boston University
OTHER
University of California, Los Angeles
OTHER
Right to Care
OTHER